Tirzepatide
10mg · lyophilized · single vial
4.6(880 researcher reviews)Dual GLP-1 / GIP receptor agonist.
- HPLC3rd-party assay
- CoAPer batch
- Cold-chainIce-packed
- DiscreetPlain packaging
For research and educational use only. Not for human consumption. Consult a licensed provider before use.
What is Tirzepatide?
Tirzepatide is a once-weekly dual agonist of GIP and GLP-1 receptors. The SURMOUNT trial program showed up to ~22.5% mean body-weight reduction at the 15 mg dose — the current benchmark among approved weight-management agents.
Every KINETYX vial is filled in a controlled cleanroom and sealed with tamper-evident packaging. Batch documentation includes identity confirmation, HPLC purity analysis and concentration verification.
What researchers are saying
Impressed with the packaging
Jul 16, 2026Been running a conservative research protocol for four weeks. Response curve is consistent with published literature.
A. RossiClinicianImpressed with the packaging
Jun 30, 2026Compared this side by side with two other suppliers. KINETYX was the only one that documented concentration verification.
D. OkaforWellness✓ Verified buyerImpressed with the packaging
Jul 4, 2026Been running a conservative research protocol for four weeks. Response curve is consistent with published literature.
L. PetrovEndurance athlete✓ Verified buyerSleep and recovery both improved
Jun 18, 2026Compared this side by side with two other suppliers. KINETYX was the only one that documented concentration verification.
K. YamadaResearcher✓ Verified buyer